Siegfried Evionnaz SA – FDA 483, Mar 31, 2023
An FDA inspection of Siegfried Evionnaz SA, an API manufacturer in Evionnaz, Switzerland, revealed significant deficiencies across three observations. These included inadequately designed and maintained production equipment, failure to monitor API stability characteristics as per procedures, and poor maintenance of buildings used for manufacturing and raw material storage, leading to water damage. The findings indicate a moderate level of concern regarding the firm's adherence to good manufacturing practices.
ID · 43a94a56-ca4a-4b09-affc-46158ba90c8d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.